Early Use of Sotrovimab in Children: A Case Report of an 11-Year-Old Kidney Transplant Recipient Infected with SARS-CoV-2

• Asıl Yazarlar: Costanza Di Chiara (Yazar), Daniele Mengato (Yazar), Marica De Pieri (Yazar), Germana Longo (Yazar), Elisa Benetti (Yazar), Francesca Venturini (Yazar), Carlo Giaquinto (Yazar), Daniele Donà (Yazar)
• Materyal Türü: Kitap
• Baskı/Yayın Bilgisi: MDPI AG, 2022-03-01T00:00:00Z.
• Konular: article
• Online Erişim: Connect to this object online.

Background: The use of virus-neutralizing monoclonal antibodies has been approved in fragile populations, including kidney transplant recipients, who are at risk of developing severe COVID-19. Sotrovimab is the only currently available anti-SARS-CoV-2 neutralizing monoclonal antibody with activity a...